Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Asset Writedowns and Impairment (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Asset Writedowns and Impairment for 16 consecutive years, with -$3.8 million as the latest value for Q3 2025.

  • Quarterly Asset Writedowns and Impairment fell 223.9% to -$3.8 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$23.6 million through Sep 2025, down 907.38% year-over-year, with the annual reading at $2.5 million for FY2024, 2337.62% up from the prior year.
  • Asset Writedowns and Impairment for Q3 2025 was -$3.8 million at Anika Therapeutics, down from $3.8 million in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $3.8 million in Q2 2025, with the low at -$23.6 million in Q4 2024.
  • Average Asset Writedowns and Impairment over 5 years is -$846500.0, with a median of $235000.0 recorded in 2021.
  • Peak annual rise in Asset Writedowns and Impairment hit 1922.55% in 2024, while the deepest fall reached 9271.43% in 2024.
  • Over 5 years, Asset Writedowns and Impairment stood at -$3.1 million in 2021, then skyrocketed by 152.48% to $1.6 million in 2022, then crashed by 115.48% to -$252000.0 in 2023, then crashed by 9271.43% to -$23.6 million in 2024, then soared by 83.73% to -$3.8 million in 2025.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at -$3.8 million, $3.8 million, and $46000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.